Search

Search Constraints

You searched for: Author/Creator Bose, Prithviraj

Search Results

51. Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma. (August 2019)

52. Phase II study of azacitidine with pembrolizumab in patients with intermediate‐1 or higher‐risk myelodysplastic syndrome. (2nd August 2021)

54. Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments. (28th March 2019)

55. Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial. Issue 2 (February 2017)

57. Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis. (17th January 2018)

58. Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3‐internal tandem duplication mutation–positive acute myeloid leukemia. Issue 21 (16th July 2019)

59. The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia‐negative B‐cell acute lymphoblastic leukemia is a strong predictor for survival. Issue 2 (19th November 2019)